Eric Cooks Shares LLS Call for Research on Clinical Trial Access Equity
Eric Cooks, Scientific Vice President, Health Services Research at American Cancer Society, shared a post on LinkedIn:
“The Leukemia & Lymphoma Society’s Equity in Access Research Program is designed to generate data that will accelerate policy impact and drive meaningful changes in healthcare practice and program delivery.
Now through September 11th, researchers are invited to submit Letters of Intent that align with the topic “Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups.” Please visit our website for additional details.
Also, please join our pre-application webinar on June 18th, noon ET. You can register here.
Join us in tackling the pervasive barriers that prevent many patients from getting the cancer care they need and deserve.”
Tricia Hernandez, Director of Community Engagement at The Leukemia and Lymphoma Society, shared the post on LinkedIn, adding:
“Are you a health researcher exploring ways to make clinical trials more accessible to all, especially those most underrepresented in clinical trials?
Check out this research opportunity from The Leukemia & Lymphoma Society’s Equity in Access Research Program!”
More posts featuring The Leukemia & Lymphoma Society.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023